The effect of zinc therapy on lysosomal inclusion bodies in intestinal epithelial cells in acrodermatitis enteropathica.
Two patients with acrodermatitis enteropathica had abnormal lysosomal inclusion bodies in the intestinal epithelial cells while in relapse but fewer smaller ones after zinc therapy. The third patient with acrodermatitis enteropathica in remission on zinc therapy had no inclusion bodies. The smaller inclusion bodies were similar to those found in coeliac disease.
D000169:Acrodermatitis / Q000188:drug therapy* / Q000473:pathology; D001706:Biopsy; D002648:Child; D002675:Child, Preschool; D004848:Epithelium / Q000473:pathology; D005260:Female; D006801:Humans; D002479:Inclusion Bodies; D007410:Intestinal Diseases / Q000188:drug therapy* / Q000473:pathology; D007583:Jejunum / Q000473:pathology; D008247:Lysosomes / Q000648:ultrastructure; D008297:Male; D015032:Zinc / Q000627:therapeutic use*
D015032:Zinc